Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome

Clinical trial NCT06698848 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06698848
Sponsor: Massachusetts General Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Depression Suicide

Start date: 2025-01-01
Primary completion: 2030-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.